Daily Dispatch

The 'Dispatched' Podcast

News EN ↓ 209 episodes

BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.

Be sure to visit the podcast's website and support the creator: bpd.captivate.fm

Author

Daily Dispatch

Category

News

Podcast website

bpd.captivate.fm

Latest episode

Nov 13, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

The 'Week in Advance' - 16 June 16.06.2023

A different approach this week with the discussion looking ahead to the end of June, with published outcomes expected on requests for relief from the stockholding commitment, detail on reform of the Opiate Dependence Treatment Program, and lots of discussions on health technology assessment.

The 'Week in Review' - 9 June 08.06.2023

Parents are showing remarkable courage in sharing their personal stories of loss in an attempt to convince the Albanese government to implement a pre-election commitment. A typo means the planned diabetes tender will proceed simultaneously with the recently announced parliamentary inquiry. How? Are 60-day dispensing and other changes going the same way as other recent reforms?

The 'Week in Review' - 2 June 02.06.2023

We focus on the Administrative Appeals Tribunal's negative reflections on the health department, the minister's criticism of 'clunky' HTA, and rugged exchanges at Budget Estimates between senators and officials on various issues, including 60-day dispensing and newborn screening.

The 'Week in Review' - 26 May 26.05.2023

Thoughts on the recent BPD annual conference and the latest on the dispute between the Albanese Government and pharmacy over the plan to increase dispensed quantities of over 300 medicines, including an interesting rumour. Readers' questions on a difficult discussion and next week's Senate Estimates hearing.

The 'Week in Review' - 19 May 18.05.2023

The 'Week in Review' was recorded at the BioPharmaDispatch annual conference and featured Cube's Anne-Marie Sparrow and Jody Fassina of Insight Strategy. We discuss the 2023-24 Budget, the ongoing fallout over the plan to increase dispensed quantities, and the range of other issues raised at Monday's event.

The 'Week in Review' - 12 May 11.05.2023

The 2023-24 Budget has revealed significant growth in the PBS in the current year. We unpack the numbers and discuss what might be driving potentially transformative growth. Health minister Mark Butler also announced reform of access arrangements for medicines for opiate dependence and nicotine e-cigarettes.

The 'Week in Review' - 5 May 04.05.2023

In a special pre-Budget episode of the 'Dispatched' week-in-review podcast, we discuss the Albanese government's move on pharmacy, how it reflects a broader policy malaise, good news for people living with opioid dependence but not so good on newborn screening, and why disability advocates should be worried if the PBS is going to be the new model for managing growth in the NDIS.

The 'Week in Review' - 28 April 26.04.2023

The Albanese Government is now in a fierce fight with the Pharmacy Guild over the plan to double dispensed prescription quantities for 325 PBS-listed medicines. Pharmacy will chip away at this issue over the next few months. What does that look like, and where does it  go?

The 'Week in Review' - 21 April 21.04.2023

Culture and capability have been the focus this week. Will new leadership lead to change? Pre-Budget announcements are now coming 'thick and fast' but what else might we expect? We respond to questions from the audience about 'secrecy' and why the absence of celebrations about the 75th anniversary of the creation of the PBS?

The 'Week in Review' - 14 April 14.04.2023

The health department is about to get new leadership, which means change, hopefully leading to less of a 'smash and grab' approach to policy development. The upcoming 2023-24 Budget may not include specific new savings measures, but that does not mean they're not in there.

The 'Week in Review' - 6 April 06.04.2023

All questions from the audience today. Questions about what the government might want from the HTA review, 'conditionality' versus the 'managed access program', and why the tinkering on patient input to decision-making?

The 'Week in Review' - 31 March 31.03.2023

Any late-breaking news on the 1 April catch-up statutory price reductions? What is happening with the Albanese government's commitment to expanding Australia's patchwork of newborn screening programs? Questions from the audience about what next on pricing policy, whether it would be unfair, and what lessons can be learned.

The 'Week in Review' - 24 March 24.03.2023

Any surprises on the finalised terms of reference for the HTA review? The very clever politics of a 'supply only' arrangement and why the term 'commercial viability' confuses patients and masks the truth of changes that 'cut too deep'.

The 'Week in Review' - 17 March 17.03.2023

A change in the membership of the federal government's HTA review reference committee. What does it say about the review and what does it mean? Still waiting for final outcomes ahead of the 1 April price changes and a question from the audience about what patients can do to ensure their voices are heard.

The 'Week in Review' - 10 March 09.03.2023

Should we make this podcast 'confidential' by saying it's confidential? The Albanese government's unprecedented decision to release the rules for its first Budget. Could the industry be 'approached' ahead of this year's Budget given the challenging fiscal circumstances and the consistent focus on the need for savings?

The 'Week in Review' - 3 March 03.03.2023

Some companies are being paid a premium to keep their medicines on the PBS and well supplied while others are having their prices slashed to the point they are exiting the program. Is anyone else confused? And, why Ernest Hemingway provides the best metaphor for how people should approach the period ahead - the fisherman, the marlin and the shark.

The 'Week in Review' - 24 February 24.02.2023

We discuss the terrible treatment of the nurse-led Centre for Community-Driven Research and why everyone should be alarmed. We also ponder the almost $60 million the federal government has agreed to pay the TGA's landlord for its new laboratories.

The 'Week in Review' - 17 February 17.02.2023

A busy 'week in review' with a discussion about the 'confidentiality' arrangement for the HTA review, with someone who knows all about those things, and a focus on yesterday's Senate Estimates hearing that saw some very interesting revelations and a new dynamic between the committee and officials.

The 'Week in Review' - 10 February 09.02.2023

Are Australian patients getting Pharmac by stealth? How is it happening and how can it be stopped? Why everyone should be concerned about changes in one important area of health and the 'Occam’s razor' in the evolution of change.

The 'Week in Review' - 3 February 03.02.2023

What did the finance department tell the HTA review reference committee about its draft terms of reference? The TGA is looking for a new leader and there is a new home for genomics policy. We also respond to a question about the wider implications of an 'approach to market' for diabetes products.

The 'Week in Review' - 27 January 26.01.2023

Another week of consternation about the health technology assessment review and some questions from the audience, including one that challenges the exclusion of people from the consultation process but another that doubts there was any alternative.

The 'Week in Review' - 20 January 20.01.2023

The year starts with another controversy, this time over the draft terms of reference for the health technology assessment review. We discuss why nobody should be surprised and respond to questions from the audience about a potential solution and why confidentiality requirements are not a feature of other major reviews in health.

The Dispatched Podcast 'Year in Review' 19.12.2022

We take a month-to-month look at 2022 with so many events, outcomes and the fallout of processes. What does it all mean, what does it say about the year and what should we all expect in 2023?

The 'Week in Review' - 16 December 16.12.2022

What is a 'probity adviser' and why has one been appointed to the health technology assessment review? Events in New Zealand continue to evolve with one patient leader making a blunt diagnosis of what's ailing the Pharmac CEO. We also answer a question about 'ministerial discretion' and suggest the real process is only just beginning.

The 'Week in Review' - 9 December 09.12.2022

The year is ending with companies receiving disappointing news on their requests for relief from next April's 'catch-up' reduction day. What does it mean now and for 2023? The horizon scanning forum and the need for clarity from the health minister about what he wants from this and all the other ongoing processes. Audience questions focus on the 'renaissance' of Australian...

Listen to the The 'Dispatched' Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.